Document Detail


Effects of utero-ovarian anastomoses on basal follicle-stimulating hormone level change after uterine artery embolization with tris-acryl gelatin microspheres.
MedLine Citation:
PMID:  16778229     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To assess the prevalence of anastomoses between uterine and ovarian arteries on angiography and their impact on changes in basal follicle-stimulating hormone (FSH) level after uterine artery embolization (UAE). MATERIALS AND METHODS: Consecutive premenopausal women who underwent UAE for symptomatic uterine leiomyomata according to a uniform embolization technique with tris-acryl gelatin microspheres at a single institution were included in the study. Basal FSH levels before UAE and 6 months after UAE were compared for patients with and without anastomoses between uterine and ovarian arteries on angiography. RESULTS: Among 124 patients included in the study (mean age, 43.1+/-5.7 years), patent anastomoses between the uterine and ovarian arteries were detected by angiography in 55 patients (44.4%). Overall, 11.3% of 124 patients showed an increase in basal serum FSH level of greater than 20 mIU/mL after UAE. In patients with utero-ovarian anastomoses, 18.2% showed an increase of greater than 20 mIU/mL after UAE, compared with 5.8% of patients without such anastomoses (P=.03). Mean basal FSH increase after UAE in patients with anastomoses was 8.4+/-20.2 mIU/mL, compared with 2.7+/-10.6 mIU/mL in patients without anastomoses (P=.047). Among patients with anastomoses, the 50- to 54-year age group had the highest percentage of patients with an FSH increase greater than 20 mIU/mL (50.0%) after UAE, followed by patients in the 45- to 49-year age group (15.4%). CONCLUSIONS: Angiographically detected anastomoses between the uterine artery and the ovarian artery are not uncommon. UAE in patients with anastomoses is associated with a greater risk of significant increase of basal FSH level than in UAE in patients without anastomoses. The pathophysiologic processes resulting in change of FSH level may be a reflection of diminished ovarian function, but further study is warranted to delineate the precise mechanism.
Authors:
Hyun S Kim; Jason Tsai; Judy M Lee; Russell Vang; John G Griffith; Edward E Wallach
Related Documents :
22701539 - External urethral sphincter pressure measurement: an accurate method for the diagnosis ...
18930219 - Does a clinical varicocele influence the relationship between testicular volume by ultr...
2161009 - Color doppler sonography in acute epididymitis and orchitis.
366849 - Medical treatment of the subfertile male.
22771289 - Parkinsonian tremor identification with multiple local field potential feature classifi...
22842299 - Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a...
15742109 - Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopath...
17963519 - Islet cell autoantibodies in african patients with type 1 and type 2 diabetes in dar es...
24467219 - Continuous low-dose cyclophosphamide and prednisone in the treatment of relapsed/refrac...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of vascular and interventional radiology : JVIR     Volume:  17     ISSN:  1051-0443     ISO Abbreviation:  J Vasc Interv Radiol     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-06-16     Completed Date:  2006-11-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203369     Medline TA:  J Vasc Interv Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  965-71     Citation Subset:  IM    
Affiliation:
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 545, Baltimore, Maryland 21205-4010, USA. sikhkim@jhmi.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acrylic Resins / therapeutic use
Angiography, Digital Subtraction
Arteriovenous Anastomosis / radiography*
Embolization, Therapeutic / methods*
Female
Follicle Stimulating Hormone / blood*
Gelatin / therapeutic use
Humans
Leiomyoma / blood,  therapy*
Middle Aged
Ovary / blood supply*,  metabolism
Premenopause
Treatment Outcome
Uterine Neoplasms / blood,  therapy*
Uterus / blood supply*,  metabolism
Chemical
Reg. No./Substance:
0/Acrylic Resins; 0/trisacryl gelatin microspheres; 9000-70-8/Gelatin; 9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper pep...
Next Document:  Midterm follow-up of a single-center experience of endovascular repair of abdominal aortic aneurysms...